🇺🇸 FDA

Drug profile · INN

albuterol

ALBUTEROL

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

albuterol (ALBUTEROL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN albuterol
Brand ALBUTEROL
Route INHALATION
Formulation AEROSOL, METERED
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 12383516

    Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7488758

    Levalbuterol hydrochloride polymorph B

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7482489

    Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

    Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7465831

    Levalbuterol hydrochloride Polymorph A

    Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is albuterol?

albuterol (ALBUTEROL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for albuterol?

ALBUTEROL is a marketed brand name for albuterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of albuterol?

albuterol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.